Regenerx Biopharmaceuticals Inc
RGRXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000707511
Regenerx Biopharmaceuticals Inc was delisted in 2023; its insiders filed their last Form 4 on Jul 6, 2023; 1 institution reported holding it in 13F filings for Q3 2023, worth $170 in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Regenerx Biopharmaceuticals Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
RGRX is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023
- Institutional holders
- 0
- −1 vs. Q3 2023
- Shares held
- 0
- −10.0K (−100.0%) vs. Q3 2023
- Total value
- $0
- −$170 (−100.0%) vs. Q3 2023
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $170 |
| Q2 2023 | 1 | $266 |
| Q1 2023 | 1 | $1.05K |
| Q4 2022 | 1 | $1.39K |
| Q3 2022 | 1 | $1.00K |
| Q2 2022 | 2 | $5.00K |
| Q1 2022 | 1 | $2.00K |
| Q4 2021 | 1 | $34.0K |
| Q3 2021 | 1 | $35.0K |
| Q2 2021 | 2 | $57.0K |
| Q1 2021 | 1 | $53.0K |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Regenerx Biopharmaceuticals Inc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Williams Jones Wealth Management, LLC. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |